Central Nervous System Pharmacology Practice Questions

Q: A 30-year-old man presents with multiple small red papules on his face and chest that appeared after starting a new medication. Which medication is most likely the cause?

Phenytoin. ***Phenytoin*** - **Phenytoin** is well-known for causing **drug-induced hypersensitivity reactions** presenting as **morbilliform (measles-like) or exanthematous eruptions** with small, red papules - These reactions typically appear within **1-3 weeks** of starting therapy and commonly affect the **face, trunk, and upper extremities** - Phenytoin can also cause more severe reactions like **DRESS syndrome** and **SJS/TEN**, making recognition of early cutaneous signs clinically important - In the context of pharmacology testing, phenytoin's dermatological side effects are **high-yield** and frequently examined *Amoxicillin* - While **amoxicillin** is a common cause of drug rashes overall (affecting 5-10% of patients), these rashes are often **delayed** (appearing 4-14 days after treatment) and frequently **non-allergic** in nature - The classic "**amoxicillin rash**" often occurs in the context of **viral infections** (especially EBV) rather than as a true drug hypersensitivity - Without additional context suggesting concurrent viral illness, other medications should be considered first *Hydrochlorothiazide* - **Hydrochlorothiazide** primarily causes **photosensitivity reactions** that require sun exposure, presenting as sunburn-like eruptions in sun-exposed areas - Can also rarely cause **lichenoid eruptions** or **vasculitis**, but generalized small red papules are not its characteristic presentation *Prednisone* - **Prednisone** is a corticosteroid with **anti-inflammatory and immunosuppressive** properties that typically **suppress rash formation** - Chronic use may cause **steroid acne** or skin atrophy, but acute papular eruptions after starting the medication are highly unlikely - Prednisone is often used to **treat** drug-induced rashes, not cause them

Q: Which antiepileptic drug is most strongly contraindicated in pregnancy due to its teratogenic effects?

Valproic acid. ***Valproic acid*** - Valproic acid is strongly **teratogenic**, associated with a high risk of **neural tube defects** (e.g., spina bifida), as well as developmental delays and cardiac abnormalities. - Due to these severe risks, it is generally **contraindicated during pregnancy**, especially in the first trimester, unless no other safer alternative is effective for severe epilepsy. *Carbamazepine* - While carbamazepine *does* have teratogenic potential, particularly increasing the risk of **neural tube defects**, its risk is generally considered lower than that of valproic acid. - It is often managed with **folic acid supplementation** if used in pregnancy, and it is not universally contraindicated, though careful consideration is necessary. *Levetiracetam* - Levetiracetam is generally considered one of the **safer antiepileptic drugs** for use during pregnancy, with relatively low rates of major congenital malformations. - It is often a preferred choice for managing epilepsy in pregnant women, weighing the risks and benefits. *Gabapentin* - Gabapentin is also generally considered to have a **lower teratogenic risk** compared to older antiepileptics like valproic acid. - While not entirely without risk, it is often favored when alternative monotherapies are not suitable or tolerated.

Q: What is the benefit of combining levodopa with carbidopa in the treatment of Parkinson's disease?

Reduces peripheral side effects of levodopa. ***Reduces peripheral side effects of levodopa*** - Carbidopa is a **dopa decarboxylase inhibitor** that does not cross the blood-brain barrier. It inhibits the peripheral conversion of levodopa to dopamine, thereby reducing peripheral side effects like **nausea**, **vomiting**, and **cardiac arrhythmias**. - By reducing peripheral metabolism, more levodopa is available to cross the **blood-brain barrier** and be converted to dopamine in the brain, improving therapeutic efficacy. *Enhances CNS penetration of levodopa* - Carbidopa itself **does not cross the blood-brain barrier**, so it cannot directly enhance the central nervous system (CNS) penetration of levodopa. - Its action is primarily in the **periphery**, preventing levodopa's premature conversion to dopamine before it reaches the brain. *Prolongs the half-life of levodopa* - While carbidopa increases the amount of levodopa available to the brain, it does not significantly **prolong the plasma half-life** of levodopa itself. - The primary effect is to **reduce peripheral metabolism**, allowing a greater proportion of the administered dose to reach the CNS. *Increases dopamine receptor sensitivity* - Carbidopa's mechanism of action involves **enzyme inhibition** (dopa decarboxylase) and does not directly affect the sensitivity of **dopamine receptors** in the brain. - Levodopa is converted to dopamine, which then acts on these receptors, but carbidopa does not modulate their sensitivity.

Q: Which of the following acetylcholinesterase inhibitors is most commonly prescribed as first-line therapy for mild to moderate Alzheimer's disease due to its once-daily dosing and favorable side effect profile?

Donepezil. ***Donepezil*** - It is frequently chosen as a **first-line agent** for mild to moderate Alzheimer's disease due to its **favorable side effect profile** and **once-daily dosing** [1]. - Its long half-life allows for administration once a day, which can improve **patient adherence** to therapy [1]. *Galantamine* - This acetylcholinesterase inhibitor typically requires **twice-daily dosing**, which is less convenient than donepezil's once-daily regimen [2]. - While effective, it does not hold the same **first-line preference** as donepezil due to its more frequent administration [2]. *Rivastigmine* - Rivastigmine is available in oral and transdermal patch formulations, but its oral form often requires **twice-daily dosing** or more [2]. - Its side effect profile can be more pronounced, particularly **gastrointestinal side effects**, compared to donepezil [2]. *All of the options* - While all listed options are acetylcholinesterase inhibitors used in Alzheimer's disease, **Donepezil** stands out as the most common first-line choice due to its once-daily dosing and well-tolerated profile [1], [2]. - The other options have different dosing schedules or side effect profiles that make them less universally preferred as initial therapy [2].

Q: A 28-year-old woman with a history of seizures is prescribed a classic anticonvulsant that primarily works by inhibiting voltage-gated sodium channels. Which drug is most likely being prescribed?

Phenytoin. ***Phenytoin*** - **Phenytoin** is the **classic prototype anticonvulsant** [1] that primarily works by **blocking voltage-gated sodium channels**, thus stabilizing the neuronal membrane and preventing repetitive firing [2]. - It is effective in treating various seizure types, including **focal** and **generalized tonic-clonic seizures** [1]. - As the traditional first-line agent in this class, it is the most likely answer when referring to a "classic" sodium channel blocker [1]. *Carbamazepine* - While **carbamazepine** also works by **blocking voltage-gated sodium channels** [2], it is structurally related to tricyclic antidepressants and came after phenytoin. - It's often used for **focal seizures** and **trigeminal neuralgia**. - Considered an important alternative but not the "classic" prototype [1]. *Valproate* - **Valproate** has **multiple mechanisms of action**, including inhibiting **GABA transaminase** (increasing GABA levels), blocking **sodium channels**, and modulating **T-type calcium channels** [2]. - Its broad spectrum is useful for both **focal** and **generalized seizures**, including absence seizures. - Not primarily classified as a sodium channel blocker due to its multiple mechanisms. *Lamotrigine* - **Lamotrigine** is a **newer anticonvulsant** [1] that inhibits presynaptic **voltage-gated sodium channels**, reducing the release of excitatory neurotransmitters like glutamate [2]. - It is effective against various seizure types, including **focal**, **generalized tonic-clonic**, and seizures associated with **Lennox-Gastaut syndrome**. - Developed later as a second-generation antiepileptic drug [1].

Q: What is the first-line treatment for a patient presenting with an acute dystonic reaction?

Anticholinergics. ***Anticholinergics*** - **Anticholinergic medications**, such as **benztropine** or **diphenhydramine**, are the **first-line treatment** for acute dystonic reactions. - They work by **blocking muscarinic acetylcholine receptors**, thereby re-establishing the balance between dopamine and acetylcholine in the basal ganglia, which is disrupted in dystonia. *Benzodiazepines* - While benzodiazepines can provide some symptomatic relief by reducing muscle spasms and anxiety, they are **not the first-line treatment** for the underlying neurological cause of acute dystonia. - They primarily act on **GABA receptors**, promoting muscle relaxation, but do not directly address the dopamine-acetylcholine imbalance. *Beta-blockers* - **Beta-blockers** are primarily used to treat conditions like **hypertension**, **anxiety**, or **essential tremor**, and are **not effective** for acute dystonic reactions. - They work by blocking beta-adrenergic receptors and have no direct role in the pathophysiology of dystonia. *Dopamine agonists* - **Dopamine agonists** are typically used to **increase dopamine activity**, as seen in conditions like **Parkinson's disease**. - Acute dystonic reactions are often caused by **dopamine receptor blockade** (e.g., by antipsychotics), so increasing dopamine agonism would generally be **contraindicated** or ineffective.

Q: A patient with Parkinson's disease is given a dopamine agonist to manage motor symptoms by directly stimulating dopamine receptors. Which drug corresponds to this description?

Pramipexole. ***Pramipexole*** - **Pramipexole** is a commonly used **non-ergot dopamine agonist** that **directly stimulates dopamine D2 and D3 receptors** in the brain. - It is effective in managing motor symptoms of **Parkinson's disease** by mimicking the effects of dopamine, particularly in early-stage disease or as an adjunct to levodopa. - Unlike levodopa, it does not require enzymatic conversion and directly activates dopamine receptors. *Levodopa* - **Levodopa** is a **dopamine precursor** that is converted into dopamine in the brain via aromatic L-amino acid decarboxylase (AADC). - It works by **replenishing deficient dopamine levels** rather than directly stimulating dopamine receptors. - It is the most effective symptomatic treatment for Parkinson's disease but is **not a dopamine agonist**. *Selegiline* - **Selegiline** is a **selective monoamine oxidase-B (MAO-B) inhibitor** that prevents the breakdown of dopamine in the brain. - It **increases dopamine availability** by blocking its metabolism but does not directly stimulate dopamine receptors. - It is used as an adjunct therapy to enhance the effects of endogenous or exogenous dopamine. *Entacapone* - **Entacapone** is a **catechol-O-methyltransferase (COMT) inhibitor** that prevents the peripheral breakdown of levodopa. - This action **prolongs the half-life of levodopa**, allowing more to cross the blood-brain barrier, but it does not directly stimulate dopamine receptors. - It is always used in combination with levodopa/carbidopa to enhance levodopa's effectiveness.

Q: Which antiepileptic drug is used for neuropathic pain and works by inhibiting voltage-gated calcium channels?

Gabapentin. ***Gabapentin*** - **Gabapentin** is a commonly used antiepileptic drug that primarily acts by binding to the **alpha-2-delta subunit of voltage-gated calcium channels**, reducing calcium influx and subsequent neurotransmitter release. - This mechanism is particularly effective in treating **neuropathic pain**, such as diabetic neuropathy and postherpetic neuralgia. *Carbamazepine* - **Carbamazepine** works primarily by blocking **voltage-gated sodium channels**, thereby stabilizing neuronal membranes and inhibiting repetitive neuronal firing. - While effective for certain types of pain, like **trigeminal neuralgia**, its primary mechanism and widespread use for general neuropathic pain differ from gabapentin. *Levetiracetam* - **Levetiracetam's** precise mechanism of action is not fully understood, but it is thought to involve binding to the **synaptic vesicle protein 2A (SV2A)**, modulating neurotransmitter release. - It is primarily used as an antiepileptic for various seizure types and is generally **not a first-line treatment for neuropathic pain**. *Lamotrigine* - **Lamotrigine** works by blocking **voltage-gated sodium channels** and, to a lesser extent, **calcium channels**, thereby stabilizing neuronal membranes and inhibiting excitatory neurotransmitter release. - While it has some efficacy in neuropathic pain, its primary mechanism and therapeutic profile are distinct from gabapentin's selective action on voltage-gated calcium channels.

Q: Ketamine acts on which of the following?

NMDA receptor. ***NMDA receptor*** - **Ketamine** primarily acts as an **N-methyl-D-aspartate (NMDA) receptor antagonist**, blocking the effects of **glutamate**. - This action leads to its **dissociative anesthetic** effects, including analgesia, amnesia, and a cataleptic state. *Glycine receptor* - The **glycine receptor** is an inhibitory ionotropic receptor, primarily found in the **spinal cord** and brainstem. - Its activation leads to **hyperpolarization** and a decrease in neuronal excitability, a mechanism distinct from ketamine's action. *GABAa receptor* - The **GABAa receptor** is the primary inhibitory neurotransmitter receptor in the brain, and drugs like **benzodiazepines** and **barbiturates** act on it to produce sedation. - While ketamine has some indirect GABAergic effects at high doses, its primary mechanism of action is not through direct binding to GABAa receptors. *Ach receptor* - The **acetylcholine (Ach) receptor** is involved in various functions, including muscle contraction (nicotinic receptors) and parasympathetic responses (muscarinic receptors). - Drugs like **atropine** and **neostigmine** target these receptors, which are not the primary site of action for **ketamine**.

Q: A patient with epilepsy is given a drug that enhances GABA activity to prevent seizure activity. Which drug is appropriate?

Valproic acid. ***Valproic acid*** - **Valproic acid** primarily enhances **GABAergic activity** by inhibiting GABA transaminase, increasing GABA synthesis, and reducing GABA reuptake, which collectively help to stabilize neuronal activity and prevent seizures. - It is a **broad-spectrum anticonvulsant** effective against various seizure types, including generalized tonic-clonic, absence, and myoclonic seizures. *Phenytoin* - **Phenytoin** works by **blocking voltage-gated sodium channels**, thereby stabilizing neuronal membranes and preventing repetitive firing of action potentials. - It is effective for **focal (partial) seizures** and generalized tonic-clonic seizures, but its primary mechanism is not direct GABA potentiation. *Gabapentin* - **Gabapentin** modulates the **voltage-gated calcium channels** (specifically the α₂δ subunit), reducing the release of excitatory neurotransmitters. - While it has broad-spectrum effects that can reduce seizure activity, its direct mechanism of action is not primarily through enhancing GABA activity. *Lamotrigine* - **Lamotrigine** stabilizes neuronal membranes by **blocking voltage-gated sodium channels** and, to a lesser extent, inhibiting voltage-gated calcium channels. - It also reduces the release of excitatory neurotransmitters like glutamate, but it does not directly enhance GABAergic transmission.

Question 1

A 30-year-old man presents with multiple small red papules on his face and chest that appeared after starting a new medication. Which medication is most likely the cause?

Accepted Answer

Phenytoin

Answer

Amoxicillin

Answer

Hydrochlorothiazide

Answer

Prednisone

Question 2

Which antiepileptic drug is most strongly contraindicated in pregnancy due to its teratogenic effects?

Accepted Answer

Valproic acid

Answer

Carbamazepine

Answer

Levetiracetam

Answer

Gabapentin

Question 3

What is the benefit of combining levodopa with carbidopa in the treatment of Parkinson's disease?

Accepted Answer

Reduces peripheral side effects of levodopa

Answer

Enhances CNS penetration of levodopa

Answer

Prolongs the half-life of levodopa

Answer

Increases dopamine receptor sensitivity

Question 4

Which of the following acetylcholinesterase inhibitors is most commonly prescribed as first-line therapy for mild to moderate Alzheimer's disease due to its once-daily dosing and favorable side effect profile?

Accepted Answer

Donepezil

Answer

Galantamine

Answer

Rivastigmine

Answer

All of the options

Question 5

A 28-year-old woman with a history of seizures is prescribed a classic anticonvulsant that primarily works by inhibiting voltage-gated sodium channels. Which drug is most likely being prescribed?

Accepted Answer

Phenytoin

Answer

Valproate

Answer

Carbamazepine

Answer

Lamotrigine

Question 6

What is the first-line treatment for a patient presenting with an acute dystonic reaction?

Accepted Answer

Anticholinergics

Answer

Benzodiazepines

Answer

Beta-blockers

Answer

Dopamine agonists

Question 7

A patient with Parkinson's disease is given a dopamine agonist to manage motor symptoms by directly stimulating dopamine receptors. Which drug corresponds to this description?

Accepted Answer

Pramipexole

Answer

Levodopa

Answer

Selegiline

Answer

Entacapone

Question 8

Which antiepileptic drug is used for neuropathic pain and works by inhibiting voltage-gated calcium channels?

Accepted Answer

Gabapentin

Answer

Carbamazepine

Answer

Levetiracetam

Answer

Lamotrigine

Question 9

Ketamine acts on which of the following?

Accepted Answer

NMDA receptor

Answer

Glycine receptor

Answer

GABAa receptor

Answer

Ach receptor

Question 10

A patient with epilepsy is given a drug that enhances GABA activity to prevent seizure activity. Which drug is appropriate?

Accepted Answer

Valproic acid

Answer

Phenytoin

Answer

Gabapentin

Answer

Lamotrigine

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?